If you have qualified potential candidates, or just want to talk more about our recruitment needs, please contact Patricia Cristadoro, our Manager of Lateral Recruiting, at pcristadoro@lowenstein.com
Lowenstein Sandler seeks lateral partners to join our firm of over 350 client service-driven lawyers.
Some of the benefits of partnership at Lowenstein Sandler are:
Your practice is valued.
Your clients are a priority.
You have autonomy to grow your practice.
Your partners are committed to your success.
Your success is rewarded.
We welcome candidates who share these priorities and who can further strengthen the work we do in key sectors, including investment funds, life sciences, and tech. Whom do we attract? Partners who are entrepreneurial and committed to building successful practices. Individuals who are enthusiastic and supportive and who want to know that their contributions will be noticed, valued, and appreciated.
Our firm takes a diverse, inclusive approach to attracting lateral lawyers who thrive in a firm culture that combines collegiality and an entrepreneurial spirit.
Sophisticated restructuring practitioners or groups who regularly represent bondholders and investment funds
Transactions and Counseling
Privacy/cybersecurity
Investment management, including fund formation, compliance, and broker-dealer
Real estate finance team, preferably representing real estate funds
Life sciences transactions, including financing, capital markets, and licensing transactions on behalf of emerging-growth biotech, specialty pharma, and medical device manufacturers, as well as investors in these life sciences businesses
Litigation
Privacy/cybersecurity
White collar litigators with a recognized practice and former government experience in New York or Washington, D.C.
IP litigation team, patents including IPR (PTAB), trademark, trade secrets, and copyrights
Sophisticated litigators and groups who regularly represent investment funds, such as hedge funds and private equity funds, life science companies, and technology companies
Antitrust
Opportunistic
Candidates with strategic fit and meaningful clients in target funds, life sciences, and technology industries
We seek to further add to the diversity of our team, and we encourage you to present diverse candidates, even if they are not in the practice areas described above.
We represent clients across a wide range of industries. Please click on any of the practice and industry links below to see a representative list of matters and clients.
Represented InSite Wireless Group, LLC in its sale to American Tower Corporation (NYSE: AMT)
Represented Serial Productions & “This American Life” (TAL) in simultaneous deals with The New York Times Company as Serial was acquired and TAL struck strategic alliance with The Times
$170,000,000
Represented PVH Corp. [NYSE:PVH] in its sale of Speedo North America Business to Pentland Group
$2,000,000,000
Represented Indorama Ventures Public Company Limited (BKK: IVL) in completed acquisition of chemicals units from Huntsman Corporation (NYSE: HUN)
$1,400,000,000
Represented TRANZACT and its management team in the sale of TRANZACT to Willis Towers Watson
$1,700,000,000
Represented The Estée Lauder Companies Inc. (NYSE: ELC) in its acquisition of Have & Be Co. Ltd.
$100,000,000
Represented Catalyst Investors in connection with a follow-on investment in the Series E funding round of BrightFarms
$193,500,000
Represented NexPhase Capital, LP in sale of FAST to Verisk Analytics, Inc.
Represented Traub Capital in acquisition of MANA Products
$200,000,000
Represented Pamplona Capital Management in growth capital equity investment in iFit, owned by ICON Health & Fitness
Represented NexPhase Capital, LP in sale of Insurance Technologies to Thomas H. Lee Partners
Represented New Mountain Capital and Topix Pharmaceuticals, Inc. in acquisition of Think Operations, LLC
$150,000,000
Represented Roth Capital Partners as underwriter in a public offering of common stock for Loop Industries (NASDAQ: LOOP)
$297,000,000
Represented an investor in a note exchange for R.R. Donnelley (NYSE: RRD)
$150,000,000
Represented Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) in an at-the-market offering
Represented H.C. Wainwright & Co. as underwriter in a public offering for Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM)
$150,000,000
Represented Celldex Therapeutics, Inc. in public offering of common stock
Represented Roth Capital Partners in a public offering for Reed’s Inc. (NASDAQ: REED)
$119,000,000
Represented Reviva Pharmaceuticals, Inc. in merger agreement with Tenzing Acquisition Corp.
Represented Sonnet BioTherapeutics, Inc. (Nasdaq: SONN) in closing of complex merger transaction with Chanticleer Holdings, Inc., including a $19,000,000 financing, spinoff, and Nasdaq listing
$90,000,000
Represented Artegraft, Inc. in sale to LeMaitre Vascular, Inc. (Nasdaq: LMAT)
Represented DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) in acquisition of Adgero Biopharmaceuticals Holdings, Inc.
$110,000,000
Represented Provention Bio in public offering of common stock
$50,000,000
Represented Matinas BioPharma Holdings, Inc. (NYSEMKT: MTNB) in an at-the-market offering
Represent Official Committee of Unsecured Creditors
Represent Official Committee of Unsecured Creditors
Represent Official Committee of Unsecured Creditors
Represent Official Committee of Unsecured Creditors
Represent Official Committee of Unsecured Creditors
Represent Official Committee of Unsecured Creditors
Represented New York Shipping Association Inc. as amicus curiae in precedent-setting dismissal of summary judgment motion brought against N.J. Gov. Phil Murphy in 3rd Circuit.
Secured summary judgment on behalf of three health care worker unions in RICO Case
Prevailed on appeal over property valuation in eminent domain dispute with Town of Kearny
Representing PSEG to defend an award of nuclear credits worth approximately $300 million every year
Representing SBB Research Group in a federal securities lawsuit filed in federal district court by the Securities and Exchange Commission
Investigated and issued a well-received formal report on allegations of physical and emotional abuse in Rutgers University’s softball program
Lowenstein Sandler is also responsive to client demands for Alternative Fee Arrangements and has successfully implemented many for our clients. To learn more about our rates and pricing structures, please contact Patricia Cristadoro at 646.414.6967 or pcristadoro@lowenstein.com.
Diversity and inclusion at Lowenstein Sandler is like a chemical reaction: When the right elements combine, possibility becomes action. We are a dynamic, interactive community of unique individuals coming together, sharing insights, challenging limits, and working creatively to provide the best client service and to help one another grow.
At our firm, diversity and inclusion is experienced and demonstrated every day and is foundational to our success. It is a promise we make to each other that challenges us to question our assumptions, embrace and explore new ideas, and commit to making Lowenstein Sandler an outstanding place to work and build a career.
1Recruitment
We actively recruit, develop, and promote lawyers and professional staff who bring a wide range of perspectives and experiences to our firm. The greatest common factor among those we recruit is a commitment to excellence.
2Benefits
From expansive parental leave for opposite-sex and same-sex couples to domestic partner benefits and flextime and telecommuting options, our benefits package is designed to support the health and wellness of all our employees.
3Career Development
When our lawyers succeed, the firm succeeds. This understanding drives us to create an environment where employees can thrive and realize their full potential. We support our lawyers’ professional and personal development through innovative development programs both in-house and in collaboration with organizations such as the Leadership Council on Legal Diversity (LCLD) and other groups focused on building a more diverse legal community.
4Employee Resource Groups
Our five employee resource groups are forums for career development, personal enrichment, community service, and fellowship. Celebrating cultural and social diversity, these groups offer exciting programming and a space for authentic engagement for members, the firm, and the community.
We value pro bono work.From its founding, Lowenstein Sandler has been committed to advancing the public interest and serving communities in need. TheLowenstein Center for the Public Interestembodies this commitment, directing the firm's strong pro bono program and other forms of civic and philanthropic engagement. Through these efforts, the center addresses significant social problems and offers meaningful assistance to low-income and other vulnerable persons along with the organizations that advocate for and support them.
2020 Pro Bono ReportThe 2020 Pro Bono Report provides an overview of the firm’s diverse efforts to stand beside our pro bono clients in their struggle to secure justice. Last year, Lowenstein dedicated more than 23,000 hours to pro bono work and served 778 pro bono clients, including populations hard-hit by the COVID-19 pandemic, on issues involving nonprofits and microbusinesses, housing, civil rights, immigration, and more.
If you have qualified potential candidates, or just want to talk more about our recruitment needs, please contact Patricia Cristadoro, our Manager of Lateral Recruiting, at pcristadoro@lowenstein.com
Investment
Private 
Venture 
Life 
Technology 
Manufacturing 
Consumer 
Private 
